DE60230327D1 - Polymorphe von clopidogrel-hydrogensulfat - Google Patents
Polymorphe von clopidogrel-hydrogensulfatInfo
- Publication number
- DE60230327D1 DE60230327D1 DE60230327T DE60230327T DE60230327D1 DE 60230327 D1 DE60230327 D1 DE 60230327D1 DE 60230327 T DE60230327 T DE 60230327T DE 60230327 T DE60230327 T DE 60230327T DE 60230327 D1 DE60230327 D1 DE 60230327D1
- Authority
- DE
- Germany
- Prior art keywords
- polymorph
- hydrogen sulphate
- clopidogrel hydrogen
- clopidogrel hydrogensulfate
- clopidogrel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34244001P | 2001-12-18 | 2001-12-18 | |
US34235101P | 2001-12-21 | 2001-12-21 | |
US34818202P | 2002-01-11 | 2002-01-11 | |
US10/074,409 US6767913B2 (en) | 2001-12-18 | 2002-02-12 | Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms |
US35915702P | 2002-02-21 | 2002-02-21 | |
PCT/US2002/040679 WO2003051362A2 (en) | 2001-12-18 | 2002-12-18 | Polymorphs of clopidogrel hydrogensulfate |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60230327D1 true DE60230327D1 (de) | 2009-01-22 |
Family
ID=27536010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60230327T Expired - Lifetime DE60230327D1 (de) | 2001-12-18 | 2002-12-18 | Polymorphe von clopidogrel-hydrogensulfat |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1467735B1 (de) |
JP (2) | JP2005514387A (de) |
KR (1) | KR100839136B1 (de) |
CN (1) | CN1620293A (de) |
AT (1) | ATE417051T1 (de) |
AU (1) | AU2002366383B2 (de) |
CA (1) | CA2470479A1 (de) |
DE (1) | DE60230327D1 (de) |
ES (1) | ES2316650T3 (de) |
HR (1) | HRP20040647A2 (de) |
HU (1) | HUP0402485A3 (de) |
IL (1) | IL162461A0 (de) |
IS (1) | IS7319A (de) |
MX (1) | MXPA04006088A (de) |
NO (1) | NO20043038L (de) |
PL (1) | PL370802A1 (de) |
PT (1) | PT1467735E (de) |
WO (1) | WO2003051362A2 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ297472B6 (cs) * | 2002-08-27 | 2006-12-13 | Zentiva, A.S. | Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I |
GB2393181A (en) * | 2002-09-19 | 2004-03-24 | Cipla Ltd | Amorphous clopidogrel |
ITMI20022228A1 (it) * | 2002-10-21 | 2004-04-22 | Dinamite Dipharma S P A | Sali di clopidogrel con acidi alchil-solforici. |
AU2003285841A1 (en) * | 2002-11-28 | 2004-06-18 | Anpharm Przedsiebiorstwo Farmaceutyczne S.A. | A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate |
US20060100231A1 (en) * | 2003-03-10 | 2006-05-11 | Hetero Drugs Limited | Amorphous clopidogrel hydrogen sulfate |
US7872019B2 (en) | 2003-03-12 | 2011-01-18 | Cadila Healthcare Limited | Polymorphs and amorphous form of (S)-(+)-clopidogrel bisulfate |
WO2005003139A1 (en) * | 2003-07-02 | 2005-01-13 | EGIS Gyógyszergyár Rt. | Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug |
HU0302029D0 (en) * | 2003-07-02 | 2003-09-29 | Egyt Gyogyszervegyeszeti Gyar | Amorphous form of an anticoagulant agent |
PL378711A1 (pl) * | 2003-07-02 | 2006-05-15 | Egis Gyorgyszergyar Rt. | Proces wytwarzania bezpostaciowej formy leku inhibitującego agregację płytek krwi |
DE10337773A1 (de) * | 2003-08-13 | 2005-03-24 | Krka Tovarna Zdravil, D.D. | Kristallisation von festen Formen von Clopidogrel-Additionssalzen |
ATE455778T1 (de) | 2003-11-03 | 2010-02-15 | Cadila Healthcare Ltd | Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat |
RU2328501C1 (ru) * | 2004-04-09 | 2008-07-10 | Ханми Фарм. Ко., ЛТД | Кристаллический клопидогрель нафталинсульфонат или его гидрат, способ его получения и содержащая его фармацевтическая композиция |
SI1740593T1 (sl) * | 2004-04-19 | 2016-08-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Postopek za pripravo polimorfne oblike I klopidogrel hidrogen sulfata |
MXPA06012128A (es) * | 2004-04-20 | 2007-01-31 | Sanofi Aventis | Sal de clopidogrel y formas polimorfas de la misma. |
ZA200608569B (en) * | 2004-04-20 | 2007-12-27 | Sanofi Aventis | Polymorphic forms of methyl (+)-(S)-alpha- (2-chlorophenyl)-6, 7-dinydrothieno[3,2-C] pyridine-5(4H) acetate hydrobromide, clopidrogel hydrobromide |
WO2005117866A1 (en) * | 2004-06-01 | 2005-12-15 | Ivax Pharmaceuticals S.R.O. | Amorphous clopidogrel hydrochloride and its antithrombotic use |
EP1693375A1 (de) * | 2005-02-21 | 2006-08-23 | KRKA, tovarna zdravil, d.d., Novo mesto | Verfahren zur Herstellung von Clopidrogel hydrogen sulfat in Form I |
KR20070009851A (ko) * | 2005-07-14 | 2007-01-19 | 씨제이 주식회사 | 클로피도그렐 황산수소염 함유 약학 조성물 |
US20090093635A1 (en) * | 2006-03-09 | 2009-04-09 | Sandor Garadnay | PROCESS FOR MAKING POLYMORPH FROM I OF (S) - (+) -METHYL-ALPHA- (2-CHLOROPHENYL) -6, 7-DYHIDRO-THIENO- [3, 2-c] PYRIDINE-5 (4H) -ACETATE HYDROGEN SULFATE |
SI22383A (sl) * | 2006-09-22 | 2008-04-30 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nov postopek sinteze klopidogrela in nove oblike njegovih farmacevtsko sprejemljivih soli |
HUP0600839A3 (en) * | 2006-11-14 | 2008-09-29 | Egis Gyogyszergyar Nyrt | Solid pharmaceutical composition containing polymorph i of clopidogrel hydrogensulfate and process for the preparation thereof |
KR101464482B1 (ko) * | 2007-05-08 | 2014-11-26 | 경동제약 주식회사 | 클로피도그렐 황산수소염을 함유하는 약학적 조성물 및 그제조방법 |
EP2107061A1 (de) | 2008-04-02 | 2009-10-07 | Krka Tovarna Zdravil, D.D., Novo Mesto | Herstellungsverfahren für optisch angereichertes Clopidogrel |
KR101130445B1 (ko) * | 2009-10-29 | 2012-03-27 | 동아제약주식회사 | 클로피도그랠 황산수소염 ⅰ형 제조방법 |
CN101962387B (zh) * | 2010-09-13 | 2013-01-30 | 成都雅途生物技术有限公司 | 一种新结晶形态的氯吡格雷硫酸氢盐及其制备方法 |
CN102358743A (zh) * | 2011-11-05 | 2012-02-22 | 江南大学 | 一种制备无定形氯吡格雷硫酸氢盐的简便方法 |
CN103006599A (zh) * | 2012-12-31 | 2013-04-03 | 广州白云山天心制药股份有限公司 | 含氯化钠药物载体的抗凝血片剂及其制备方法 |
CN103408567B (zh) * | 2013-07-18 | 2016-12-28 | 浙江普洛医药科技有限公司 | 一种制备硫酸氢氯吡格雷晶型ⅰ的方法 |
CN104610274B (zh) * | 2013-11-05 | 2017-04-19 | 亚宝药业集团股份有限公司 | 一种i型氯吡格雷硫酸氢盐的制备方法 |
US9701636B2 (en) | 2013-11-15 | 2017-07-11 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof |
CN104045653A (zh) * | 2014-07-15 | 2014-09-17 | 苏州天马精细化学品股份有限公司 | 一种硫酸氢氯吡格雷的纯化方法 |
KR101710922B1 (ko) | 2015-06-03 | 2017-02-28 | 경동제약 주식회사 | 클로피도그렐 황산염 결정형 i형의 제조방법 |
CN107163060B (zh) * | 2017-05-24 | 2021-03-02 | 常州制药厂有限公司 | 一种硫酸氢氯吡格雷晶型ii制备方法 |
CN107337683B (zh) * | 2017-08-16 | 2019-08-16 | 中荣凯特(北京)生物科技有限公司 | 一种噻吩并吡啶类衍生物硫酸氢盐的晶型ⅱ及其制备方法和应用 |
CN112399969B (zh) * | 2018-07-12 | 2023-10-27 | 有机合成药品工业株式会社 | 硫酸氢氯吡格雷的ⅰ型晶体的制备方法 |
KR102220480B1 (ko) * | 2019-02-13 | 2021-02-25 | 한국바이오켐제약 주식회사 | 클로피도그렐황산염의 제조방법 및 이를 포함하는 약학제제 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2623810B2 (fr) * | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
FR2664276B1 (fr) * | 1990-07-04 | 1992-10-23 | Sanofi Sa | Derive thienyl-2 glycidique, son procede de preparation et son utilisation comme intermediaire de synthese. |
US5576328A (en) * | 1994-01-31 | 1996-11-19 | Elf Sanofi | Method for the secondary prevention of ischemic events |
FR2751540B1 (fr) * | 1996-07-26 | 1998-10-16 | Sanofi Sa | Composition pharmaceutique antithrombotique |
FR2769313B1 (fr) * | 1997-10-06 | 2000-04-21 | Sanofi Sa | Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese |
FR2779726B1 (fr) * | 1998-06-15 | 2001-05-18 | Sanofi Sa | Forme polymorphe de l'hydrogenosulfate de clopidogrel |
AU2002356430A1 (en) * | 2002-12-09 | 2004-06-30 | Hetero Drugs Limited | A novel polymorph of clopidogrel hydrogen sulfate |
-
2002
- 2002-12-18 DE DE60230327T patent/DE60230327D1/de not_active Expired - Lifetime
- 2002-12-18 PT PT02805215T patent/PT1467735E/pt unknown
- 2002-12-18 EP EP02805215A patent/EP1467735B1/de not_active Expired - Lifetime
- 2002-12-18 PL PL02370802A patent/PL370802A1/xx unknown
- 2002-12-18 MX MXPA04006088A patent/MXPA04006088A/es not_active Application Discontinuation
- 2002-12-18 IL IL16246102A patent/IL162461A0/xx unknown
- 2002-12-18 CA CA002470479A patent/CA2470479A1/en not_active Abandoned
- 2002-12-18 AU AU2002366383A patent/AU2002366383B2/en not_active Expired - Fee Related
- 2002-12-18 JP JP2003552295A patent/JP2005514387A/ja active Pending
- 2002-12-18 ES ES02805215T patent/ES2316650T3/es not_active Expired - Lifetime
- 2002-12-18 HU HU0402485A patent/HUP0402485A3/hu unknown
- 2002-12-18 WO PCT/US2002/040679 patent/WO2003051362A2/en active Application Filing
- 2002-12-18 KR KR1020047009420A patent/KR100839136B1/ko not_active IP Right Cessation
- 2002-12-18 CN CNA028282043A patent/CN1620293A/zh active Pending
- 2002-12-18 AT AT02805215T patent/ATE417051T1/de not_active IP Right Cessation
-
2004
- 2004-06-16 IS IS7319A patent/IS7319A/is unknown
- 2004-07-15 HR HR20040647A patent/HRP20040647A2/hr not_active Application Discontinuation
- 2004-07-16 NO NO20043038A patent/NO20043038L/no not_active Application Discontinuation
-
2009
- 2009-02-19 JP JP2009036569A patent/JP2009108107A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
IS7319A (is) | 2004-06-16 |
MXPA04006088A (es) | 2004-09-27 |
WO2003051362A3 (en) | 2003-08-07 |
KR20040066917A (ko) | 2004-07-27 |
CN1620293A (zh) | 2005-05-25 |
HUP0402485A3 (en) | 2008-10-28 |
CA2470479A1 (en) | 2003-06-26 |
HUP0402485A2 (hu) | 2005-04-28 |
PL370802A1 (en) | 2005-05-30 |
JP2005514387A (ja) | 2005-05-19 |
PT1467735E (pt) | 2009-03-10 |
EP1467735A4 (de) | 2005-11-23 |
EP1467735A2 (de) | 2004-10-20 |
IL162461A0 (en) | 2005-11-20 |
EP1467735B1 (de) | 2008-12-10 |
KR100839136B1 (ko) | 2008-06-20 |
NO20043038L (no) | 2004-09-09 |
ATE417051T1 (de) | 2008-12-15 |
WO2003051362A2 (en) | 2003-06-26 |
AU2002366383B2 (en) | 2007-06-14 |
ES2316650T3 (es) | 2009-04-16 |
JP2009108107A (ja) | 2009-05-21 |
HRP20040647A2 (en) | 2005-04-30 |
AU2002366383A1 (en) | 2003-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60230327D1 (de) | Polymorphe von clopidogrel-hydrogensulfat | |
CL2010000204A1 (es) | Compuestos intermediarios derivados de 4 amino-3-metoxibenzamida; compuesto intermediario n-{4-[4-(ciclopropilmetil)piperazin-1-il]ciclohexil}acetamida; compuesto intermediario 2-cloro-7-etil-7,8-dihidro-5-metil-8-(1-metiletil)-6(5h)-pteridinona, útiles en la preparación de dihidropteridinonas sustituidas (divisional sol. 2077-05). | |
EA200400368A1 (ru) | Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств | |
MXPA05013752A (es) | Procedimiento e intermediarios para la preparacion de (1r,2s,5s)-6,6-dimetil-3-azabiciclo[3,1,0]exan-2-carboxilatos o sales de los mismos. | |
MXPA06001494A (es) | Compuestos de piramidina condensados como inhibidores de canales ionicos gatillados por tension. | |
WO2006066950A3 (de) | Tricyclische aminoalkohole, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer | |
BR0014352A (pt) | Cetoenóis espirocìclicos substituìdos por trifluormetila | |
BR0208365A (pt) | Derivados de 2-amino-propanol | |
DE602004013405D1 (de) | Polymorphe formen von valsartan | |
AU2003279337A1 (en) | Direct process for the manufacture of tetraalkylammonium tetrafluoroborate-containing electrolyte compositions | |
EA200600621A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
DE602004024213D1 (en) | Aminopropanolderivate | |
MXPA03011954A (es) | Nuevos derivados de acido sulfonico. | |
ATE347555T1 (de) | 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung | |
MX2007002833A (es) | Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios. | |
HRP20051005A2 (en) | Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives | |
WO2004043379A3 (en) | Chemical compounds | |
DK1532131T3 (da) | Motilid-forbindelser | |
RS88704A (en) | Acyl-3-carboxyphenylurea derivatives, method for production and use thereof | |
DK1501838T3 (da) | Fremgangsmåde til fremstilling af clopidogrel | |
GB0103240D0 (en) | Organic compounds | |
DE60323748D1 (de) | 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung | |
IS8034A (is) | Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla | |
FR2823503B1 (fr) | Nouveaux composes, procede de fabrication, utilisation comme pigments et composition cosmetique | |
AU2003266093A1 (en) | Cyclooct-(en-)yl derivatives for use as fragrances |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |